These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20823704)

  • 41. A premature termination mutation in a patient with Lowe syndrome without congenital cataracts: dropping the "O" in OCRL.
    Pasternack SM; Böckenhauer D; Refke M; Tasic V; Draaken M; Conrad C; Born M; Betz RC; Reutter H; Ludwig M
    Klin Padiatr; 2013 Jan; 225(1):29-33. PubMed ID: 22915452
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Duplication of OCRL and adjacent genes associated with autism but not Lowe syndrome.
    Schroer RJ; Beaudet AL; Shinawi M; Sahoo T; Patel A; Sun Q; Skinner C; Stevenson RE
    Am J Med Genet A; 2012 Oct; 158A(10):2602-5. PubMed ID: 22965764
    [TBL] [Abstract][Full Text] [Related]  

  • 43. OCRL-mutated fibroblasts from patients with Dent-2 disease exhibit INPP5B-independent phenotypic variability relatively to Lowe syndrome cells.
    Montjean R; Aoidi R; Desbois P; Rucci J; Trichet M; Salomon R; Rendu J; Fauré J; Lunardi J; Gacon G; Billuart P; Dorseuil O
    Hum Mol Genet; 2015 Feb; 24(4):994-1006. PubMed ID: 25305077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Lowe syndrome].
    Endo F; Kawano T
    Ryoikibetsu Shokogun Shirizu; 2001; (36):473-6. PubMed ID: 11596441
    [No Abstract]   [Full Text] [Related]  

  • 45. Lowe syndrome with extremely short stature: growth hormone deficiency may be the pathogeny.
    Dai C; Wang L; Li Y; Zheng Z; Qian J; Wang C; Liu Z; Shan X
    Growth Factors; 2019 Aug; 37(3-4):170-177. PubMed ID: 31576764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe.
    Leahey AM; Charnas LR; Nussbaum RL
    Hum Mol Genet; 1993 Apr; 2(4):461-3. PubMed ID: 8504307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Oculocerebrorenal syndrome of Lowe].
    Owada M; Minowa A; Suhara Y
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):588-92. PubMed ID: 9645142
    [No Abstract]   [Full Text] [Related]  

  • 48. Incomplete cryptic splicing by an intronic mutation of OCRL in patients with partial phenotypes of Lowe syndrome.
    Nakano E; Yoshida A; Miyama Y; Yabuuchi T; Kajiho Y; Kanda S; Miura K; Oka A; Harita Y
    J Hum Genet; 2020 Oct; 65(10):831-839. PubMed ID: 32427950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of splicing assays to detect an intronic variant of the OCRL gene in Lowe syndrome.
    Nakanishi K; Nozu K; Hiramoto R; Minamikawa S; Yamamura T; Fujimura J; Horinouchi T; Ninchoji T; Kaito H; Morisada N; Ishimori S; Nakanishi K; Morioka I; Awano H; Matsuo M; Iijima K
    Eur J Med Genet; 2017 Dec; 60(12):631-634. PubMed ID: 28803024
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and functional characterization of a hemizygous novel intronic variant in OCRL gene causes Lowe syndrome.
    Sun J; Zhou Z; Weng C; Wang C; Chen J; Feng X; Yu P; Qi M
    Clin Exp Nephrol; 2020 Aug; 24(8):657-665. PubMed ID: 32394213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kidney Tubular Ablation of
    Inoue K; Balkin DM; Liu L; Nandez R; Wu Y; Tian X; Wang T; Nussbaum R; De Camilli P; Ishibe S
    J Am Soc Nephrol; 2017 May; 28(5):1399-1407. PubMed ID: 27895154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dent's disease and Lowe's syndrome: a phenotypic spectrum of one gene.
    Gupta A; Bhowmik DM; Khaira A; Singh B; Tiwari SC
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):155-6. PubMed ID: 20061714
    [No Abstract]   [Full Text] [Related]  

  • 53. Carrier assessment in families with lowe oculocerebrorenal syndrome: novel mutations in the OCRL1 gene and correlation of direct DNA diagnosis with ocular examination.
    Röschinger W; Muntau AC; Rudolph G; Roscher AA; Kammerer S
    Mol Genet Metab; 2000 Mar; 69(3):213-22. PubMed ID: 10767176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypotonia and delayed motor development as an early presentation of Lowe syndrome: case report and literature review.
    David S; De Waele K; De Wilde B; Faes F; Vanakker O; Walraedt S; Prytuła A
    Acta Clin Belg; 2019 Dec; 74(6):460-464. PubMed ID: 30501482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dent-2 disease: a mild variant of Lowe syndrome.
    Bökenkamp A; Böckenhauer D; Cheong HI; Hoppe B; Tasic V; Unwin R; Ludwig M
    J Pediatr; 2009 Jul; 155(1):94-9. PubMed ID: 19559295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome.
    Lin T; Orrison BM; Leahey AM; Suchy SF; Bernard DJ; Lewis RA; Nussbaum RL
    Am J Hum Genet; 1997 Jun; 60(6):1384-8. PubMed ID: 9199559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel interstitial deletion in Xq25, identified by array-CGH in a patient with Lowe syndrome.
    Addis M; Meloni C; Congiu R; Santaniello S; Emma F; Zuffardi O; Ciccone R; Cao A; Melis MA; Cau M
    Eur J Med Genet; 2007; 50(1):79-84. PubMed ID: 17142121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Onset mechanism of a female patient with Dent disease 2.
    Okamoto T; Sakakibara N; Nozu K; Takahashi T; Hayashi A; Sato Y; Nagano C; Matsuo M; Iijima K; Manabe A
    Clin Exp Nephrol; 2020 Oct; 24(10):946-954. PubMed ID: 32666344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.
    De Matteis MA; Staiano L; Emma F; Devuyst O
    Nat Rev Nephrol; 2017 Aug; 13(8):455-470. PubMed ID: 28669993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The oculocerebrorenal syndrome of Lowe.
    Lavin CW; McKeown CA
    Int Ophthalmol Clin; 1993; 33(2):179-91. PubMed ID: 8325732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.